Advertisement

Submit Manuscripts
Author Information
Subscribe/Renew
Order Reprints
Email Alerts
Feedback
RSS Feed
CME

About the Journal
Editorial Board & Staff

JACC Imaging Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?
Click here
to sign up now!

ACC.org
Cardiosmart
Cardiosource
CVN
Imaging Library
JACC Imaging
JACC Interventions

Click here for more guidelines.
ACCF/ASNC/ACR/
AHA/ASE/SCCT/
SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging
SCIENCE ADVISORY: Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 38:307-314
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valen, G.
Right arrow Articles by Hansson, G.o. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valen, G.
Right arrow Articles by Hansson, G.o. K.

REVIEW ARTICLE

Nuclear factor kappa-B and the heart

Guro Valen, MD, PhD*, Zhong-qun Yan, PhD{dagger} and G.öran K. Hansson, MD, PhD{dagger}

* Crafoord Laboratory of Experimental Surgery, Karolinska Hospital, Stockholm, Sweden
{dagger} Center of Molecular Medicine, Karolinska Hospital, Stockholm, Sweden

Manuscript received November 29, 2000; revised manuscript received April 11, 2001, accepted April 25, 2001.

Reprint requests and correspondence: Dr. Guro Valen, Crafoord Laboratory of Experimental Surgery L6:00, Karolinska Hospital, S-171 76 Stockholm, Sweden
Guro.Valen{at}cmm.ki.se

Nuclear factor kappa-B (NF{kappa}B), a redox-sensitive transcription factor regulating a battery of inflammatory genes, has been indicated to play a role in the development of numerous pathological states. Activation of NF{kappa}B induces gene programs leading to transcription of factors that promote inflammation, such as leukocyte adhesion molecules, cytokines, and chemokines, although some few substances with possible anti-inflammatory effects are also NF{kappa}B regulated. The present article reviews basic regulation of NF{kappa}B and its activation, cell biological effects of NF{kappa}B activation and the role of NF{kappa}B in apoptosis. Evidence involving NF{kappa}B as a key factor in the pathophysiology of ischemia-reperfusion injury and heart failure is discussed. Although activation of NF{kappa}B induces pro-inflammatory genes, it has lately been indicated that the transcription factor is involved in the signaling of endogenous myocardial protection evoked by ischemic preconditioning. A possible role of NF{kappa}B in the development of atherosclerosis and unstable coronary syndromes is discussed. Nuclear factor kappa-B may be a new therapeutic target for myocardial protection.

Abbreviations and Acronyms
  IAP = inhibitor of apoptosis
  ICAM = intercellular adhesion molecule
  IL = interleukin
  I{kappa}B = inhibitory kappa-B
  IKK = inhibitory kappa-B kinase complex
  LPS = lipopolysaccharide
  MAPK = mitogen-activated protein kinase
  NF{kappa}B = nuclear factor kappa-B
  NO = nitric oxide
  TLR = toll-like receptor
  TNF-{alpha} = tumor necrosis factor-alpha
  XIAP = X-linked inhibitor of apoptosis protein




This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
M. K. Duda, K. M. O'Shea, and W. C. Stanley
{omega}-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential
Cardiovasc Res, June 20, 2009; (2009) cvp169v2.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
G. Valen
Extracardiac approaches to protecting the heart
Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 651 - 657.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
G. Czibik, Z. Wu, G. P. Berne, M. Tarkka, J. Vaage, J. Laurikka, O. Jarvinen, and G. Valen
Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia-inducible factor 1 alpha in the heart
Eur. J. Cardiothorac. Surg., November 1, 2008; 34(5): 976 - 984.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
N. C. Moss, R.-H. Tang, M. Willis, W. E. Stansfield, A. S. Baldwin, and C. H. Selzman
Inhibitory kappa B kinase-beta is a target for specific nuclear factor kappa B-mediated delayed cardioprotection.
J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1274 - 1279.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Das, S. Gupta, A. Vasanji, Z. Xu, S. Misra, and S. Sen
Nuclear Co-translocation of Myotrophin and p65 Stimulates Myocyte Growth: REGULATION BY MYOTROPHIN HAIRPIN LOOPS
J. Biol. Chem., October 10, 2008; 283(41): 27947 - 27956.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
A. Lockett, M. G. Goebl, and M. A. Harrington
Transient membrane recruitment of IRAK-1 in response to LPS and IL-1{beta} requires TNF R1
Am J Physiol Cell Physiol, August 1, 2008; 295(2): C313 - C323.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
N. C. Moss, W. E. Stansfield, M. S. Willis, R.-H. Tang, and C. H. Selzman
IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2248 - H2253.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
I. A. Williams and D. G. Allen
The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1969 - H1977.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
O. J. Liakopoulos, J. D. Schmitto, S. Kazmaier, A. Brauer, M. Quintel, F. A. Schoendube, and H. Dorge
Cardiopulmonary and Systemic Effects of Methylprednisolone in Patients Undergoing Cardiac Surgery
Ann. Thorac. Surg., July 1, 2007; 84(1): 110 - 119.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Liuzzo, M. Santamaria, L. M. Biasucci, M. Narducci, V. Colafrancesco, A. Porto, S. Brugaletta, M. Pinnelli, V. Rizzello, A. Maseri, et al.
Persistent Activation of Nuclear Factor Kappa-B Signaling Pathway in Patients With Unstable Angina and Elevated Levels of C-Reactive Protein: Evidence for a Direct Proinflammatory Effect of Azide and Lipopolysaccharide-Free C-Reactive Protein on Human Monocytes Via Nuclear Factor Kappa-B Activation
J. Am. Coll. Cardiol., January 16, 2007; 49(2): 185 - 194.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
I Strickland and S Ghosh
Use of cell permeable NBD peptides for suppression of inflammation
Ann Rheum Dis, November 1, 2006; 65(suppl_3): iii75 - iii82.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
K. Hinokiyama, G. Valen, S. Tokuno, J. B. Vedin, and J. Vaage
Vein graft harvesting induces inflammation and impairs vessel reactivity.
Ann. Thorac. Surg., October 1, 2006; 82(4): 1458 - 1464.
[Abstract] [Full Text] [PDF]

Home page
 ICVTSHome page
U. M. Fischer, A. Antonyan, W. Bloch, and U. Mehlhorn
Impact of antioxidative treatment on nuclear factor kappa-B regulation during myocardial ischemia-reperfusion
Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 531 - 535.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
T. A. Baudino, W. Carver, W. Giles, and T. K. Borg
Cardiac fibroblasts: friend or foe?
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1015 - H1026.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
O. J. Liakopoulos, N. Teucher, C. Muhlfeld, P. Middel, G. Heusch, F. A. Schoendube, and H. Dorge
Prevention of TNFalpha-associated myocardial dysfunction resulting from cardiopulmonary bypass and cardioplegic arrest by glucocorticoid treatment.
Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 263 - 270.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
H. T. Lee, M. Kim, M. Jan, and C. W. Emala
Anti-inflammatory and antinecrotic effects of the volatile anesthetic sevoflurane in kidney proximal tubule cells
Am J Physiol Renal Physiol, July 1, 2006; 291(1): F67 - F78.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Back, D.-x. Bu, R. Branstrom, Y. Sheikine, Z.-Q. Yan, and G. K. Hansson
Leukotriene B4 signaling through NF-{kappa}B-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia
PNAS, November 29, 2005; 102(48): 17501 - 17506.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
W. Chao, Y. Shen, L. Li, H. Zhao, S. E. Meiler, S. A. Cook, and A. Rosenzweig
Fas-associated death-domain protein inhibits TNF-{alpha} mediated NF-{kappa}B activation in cardiomyocytes
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2073 - H2080.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G. Hall, I. S. Singh, L. Hester, J. D. Hasday, and T. B. Rogers
Inhibitor-{kappa}B kinase-{beta} regulates LPS-induced TNF-{alpha} production in cardiac myocytes through modulation of NF-{kappa}B p65 subunit phosphorylation
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2103 - H2111.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
E. A. Jankowska, S. von Haehling, A. Czarny, E. Zaczynska, A. Kus, S. D. Anker, W. Banasiak, and P. Ponikowski
Activation of the NF-{kappa}B system in peripheral blood leukocytes from patients with chronic heart failure
Eur J Heart Fail, October 1, 2005; 7(6): 984 - 990.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. V. Podgoreanu, G. A. Michelotti, Y. Sato, M. P. Smith, S. Lin, R. W. Morris, H. P. Grocott, J. P. Mathew, and D. A. Schwinn
Differential cardiac gene expression during cardiopulmonary bypass: Ischemia-independent upregulation of proinflammatory genes
J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 330 - 339.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. Brown, M. McGuinness, T. Wright, X. Ren, Y. Wang, G. P. Boivin, H. Hahn, A. M. Feldman, and W. K. Jones
Cardiac-specific blockade of NF-{kappa}B in cardiac pathophysiology: differences between acute and chronic stimuli in vivo
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H466 - H476.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
B. Xu, G.-h. Dong, H. Liu, Y.-q. Wang, H.-w. Wu, and H. Jing
Recombinant Human Erythropoietin Pretreatment Attenuates Myocardial Infarct Size: A Possible Mechanism Involves Heat Shock Protein 70 and Attenuation of Nuclear Factor-kappaB
Ann. Clin. Lab. Sci., April 1, 2005; 35(2): 161 - 168.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev, October 1, 2004; 84(4): 1381 - 1478.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. Loverre, P. Ditonno, A. Crovace, L. Gesualdo, E. Ranieri, P. Pontrelli, G. Stallone, B. Infante, A. Schena, S. Di Paolo, et al.
Ischemia-Reperfusion Induces Glomerular and Tubular Activation of Proinflammatory and Antiapoptotic Pathways: Differential Modulation by Rapamycin
J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2675 - 2686.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
L. G. Melo, M. Gnecchi, A. S. Pachori, D. Kong, K. Wang, X. Liu, R. E. Pratt, and V. J. Dzau
Endothelium-Targeted Gene and Cell-Based Therapies for Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1761 - 1774.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
E. Napoleone, A. Di Santo, G. Peri, A. Mantovani, G. de Gaetano, M. B. Donati, and R. Lorenzet
The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation
J. Leukoc. Biol., July 1, 2004; 76(1): 203 - 209.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
I. B. DeMeritt, L. E. Milford, and A. D. Yurochko
Activation of the NF-{kappa}B Pathway in Human Cytomegalovirus-Infected Cells Is Necessary for Efficient Transactivation of the Major Immediate-Early Promoter
J. Virol., May 1, 2004; 78(9): 4498 - 4507.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Takada, S. Singh, and B. B. Aggarwal
Identification of a p65 Peptide That Selectively Inhibits NF-{kappa} B Activation Induced by Various Inflammatory Stimuli and Its Role in Down-regulation of NF-{kappa}B-mediated Gene Expression and Up-regulation of Apoptosis
J. Biol. Chem., April 9, 2004; 279(15): 15096 - 15104.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
G. Reiterer, M. Toborek, and B. Hennig
Quercetin Protects Against Linoleic Acid-Induced Porcine Endothelial Cell Dysfunction
J. Nutr., April 1, 2004; 134(4): 771 - 775.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. J. O'Brien, I. Loke, J. E. Davies, I. B. Squire, and L. L. Ng
Myotrophin in human heart failure
J. Am. Coll. Cardiol., August 20, 2003; 42(4): 719 - 725.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
C.J. Malkin, P.J. Pugh, T.H. Jones, and K.S. Channer
Testosterone for secondary prevention in men with ischaemic heart disease?
QJM, July 1, 2003; 96(7): 521 - 529.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Qing, K. Schumacher, R. Heise, M. Woltje, J. F. Vazquez-Jimenez, T. Richter, M. Arranda-Carrero, J. Hess, G.o. von Bernuth, and M.-C. Seghaye
Intramyocardial synthesis of pro- and anti-inflammatory cytokines in infants with congenital cardiac defects
J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2266 - 2274.
[Abstract] [Full Text] [PDF]

Home page
 ICVTSHome page
A. Ruusalepp, J. Vaage, and G. Valen
A model of neointima formation in the atherosclerotic carotid artery of mice
Interactive CardioVascular and Thoracic Surgery, June 1, 2003; 2(2): 196 - 200.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
H. Huang, S. B. Petkova, A. W. Cohen, B. Bouzahzah, J. Chan, J.-n. Zhou, S. M. Factor, L. M. Weiss, M. Krishnamachary, S. Mukherjee, et al.
Activation of Transcription Factors AP-1 and NF-{kappa}B in Murine Chagasic Myocarditis
Infect. Immun., May 1, 2003; 71(5): 2859 - 2867.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
Z S Nedeljkovic, N Gokce, and J Loscalzo
Mechanisms of oxidative stress and vascular dysfunction
Postgrad. Med. J., April 1, 2003; 79(930): 195 - 200.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. Tahepold, J. Vaage, J. Starkopf, and G. Valen
Hyperoxia elicits myocardial protection through a nuclear factor {kappa}B-dependent mechanism in the rat heart
J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 650 - 660.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. Frantz, D. Fraccarollo, H. Wagner, T. M Behr, P. Jung, C. E Angermann, G. Ertl, and J. Bauersachs
Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure
Cardiovasc Res, March 1, 2003; 57(3): 749 - 756.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
G. Valen
The basic biology of apoptosis and its implications for cardiac function and viability
Ann. Thorac. Surg., February 1, 2003; 75(2): S656 - 660.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. Vaage and G. Valen
Preconditioning and cardiac surgery
Ann. Thorac. Surg., February 1, 2003; 75(2): S709 - 714.
[Abstract] [Full Text] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
C. COTSAPAS, E. CHAN, M. KIRK, M. TANAKA, and P. LITTLE
Genetic Variation and the Control of Transcription
Cold Spring Harb Symp Quant Biol, January 1, 2003; 68(0): 109 - 114.
[Abstract] [PDF]

Home page
 Circ. Res.Home page
I. Manabe, T. Shindo, and R. Nagai
Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy
Circ. Res., December 13, 2002; 91(12): 1103 - 1113.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. Dong and P. J. Goldschmidt-Clermont
E2F1: A Magic Bullet for Atherosclerosis?
Circulation, November 19, 2002; 106(21): 2640 - 2641.
[Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
F. Al-Mohanna, S. Saleh, R. S. Parhar, and K. Collison
IL-12-dependent nuclear factor-{kappa}B activation leads to de novo synthesis and release of IL-8 and TNF-{alpha} in human neutrophils
J. Leukoc. Biol., November 1, 2002; 72(5): 995 - 1002.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
N. K. Chanani, D. B. Cowan, K. Takeuchi, D. N. Poutias, L. M. Garcia, P. J. del Nido, and F. X. McGowan Jr
Differential Effects of Amrinone and Milrinone Upon Myocardial Inflammatory Signaling
Circulation, September 24, 2002; 106(12_suppl_1): I-284 - I-289.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. M Smith, S. Lecour, and M. N Sack
Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program
Cardiovasc Res, August 15, 2002; 55(3): 474 - 482.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
P. Tahepold, A. Ruusalepp, G. Li, J. Vaage, J. Starkopf, and G. Valen
Cardioprotection by breathing hyperoxic gas--relation to oxygen concentration and exposure time in rats and mice
Eur. J. Cardiothorac. Surg., June 1, 2002; 21(6): 987 - 994.
[Abstract] [Full Text] [PDF]


 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement